V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006300 | 330003097 | null | 52 | Curative (C) | 2014-03-04 | 2014-03-04 | Cisplatin + Radiotherapy | 02 | Y | 330000847 | CISPLATIN + RT |
| 330006301 | 330003097 | 1.65 | 55.8 | Curative (C) | 2017-10-25 | 2017-11-20 | Cisplatin + Radiotherapy | 2 | null | 330000847 | CISPLATIN + RT |
| 330006302 | 330003098 | 1.98 | null | Adjuvant (A) | 2015-08-16 | 2015-08-16 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330000854 | CISPLATIN + RT |
| 330006303 | 330003098 | 0 | 12.3 | Palliative (P) | 2014-12-10 | 2014-12-13 | EW EuroEwing 2012 Arm B VC | N | Y | 330000854 | NOT MATCHED |
| 330006304 | 330003099 | 0 | null | Curative (C) | 2014-12-10 | 2014-12-10 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330000855 | CISPLATIN + RT |
| 330006305 | 330003099 | 1.77 | 90.5 | Curative (C) | 2013-11-03 | 2013-11-07 | Cisplatin + Radiotherapy | 02 | Y | 330000855 | CISPLATIN + RT |
| 330006306 | 330003100 | null | 7.9 | null | 2018-02-27 | 2018-03-07 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 330000864 | NOT MATCHED |
| 330006307 | 330003101 | 0 | 13.1 | Curative (C) | 2013-03-05 | 2013-04-03 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | 01 | N | 330000867 | NOT MATCHED |
| 330006308 | 330003103 | 0 | 63.4 | Disease modification (D) | 2013-10-23 | 2013-11-18 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330000868 | NOT MATCHED |
| 330006309 | 330003104 | 1.86 | 82 | Curative (C) | 2014-08-21 | 2014-08-29 | EW Rel rEECur Topotecan/Cyclophosphamide | 2 | N | 330000868 | NOT MATCHED |
| 330006310 | 330003106 | null | 81.85 | Curative (C) | 2017-09-29 | 2017-10-02 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330000887 | CISPLATIN + RT |
| 330006311 | 330003106 | 1.5 | 12 | Curative (C) | 2015-02-23 | 2015-02-23 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330000887 | NOT MATCHED |
| 330006312 | 330003108 | 1.06 | 7.1 | Curative (C) | 2012-11-30 | 2013-09-03 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330000894 | NOT MATCHED |
| 330006313 | 330007662 | 1.52 | 28.1 | Curative (C) | 2013-01-03 | 2013-02-04 | NB HRNBL-1 TVD | N | null | 330000894 | NOT MATCHED |
| 330006314 | 330007662 | 1.04 | 10.6 | Curative (C) | 2017-03-26 | 2017-04-05 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | N | 330000894 | NOT MATCHED |
| 330006315 | 330007662 | 0.98 | 60.5 | Palliative (P) | 2013-09-18 | 2013-09-30 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330000894 | NOT MATCHED |
| 330006316 | 330003113 | null | 16.05 | Curative (C) | 2014-08-19 | 2014-08-19 | NB HRNBL-1 ch14.18/CHO only (trial) | Y | N | 330000924 | NOT MATCHED |
| 330006317 | 330003113 | 1.88 | 23.8 | Neo-adjuvant (N) | 2014-10-07 | 2014-10-07 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | 0 | 330000924 | NOT MATCHED |
| 330006318 | 330007664 | 0 | 6.2 | Curative (C) | 2017-08-21 | 2017-11-27 | NB HRNBL-1 TVD | N | N | 330000930 | NOT MATCHED |
| 330006319 | 330003115 | 0.96 | 57 | Curative (C) | 2014-02-25 | 2014-04-26 | NB HRNBL-1 TVD | Y | N | 330000933 | NOT MATCHED |
| 330006320 | 330003116 | null | 68.7 | Adjuvant (A) | 2017-11-09 | 2017-12-09 | CISPLATIN + RT | N | Y | 330000933 | CISPLATIN + RT |
| 330006321 | 330003117 | 1.65 | 43.3 | Neo-adjuvant (N) | 2018-06-07 | 2018-07-04 | CISPLATIN + RT | null | N | 330000945 | CISPLATIN + RT |
| 330006322 | 330003118 | null | 71.5 | Neo-adjuvant (N) | 2014-10-29 | 2014-10-29 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330000949 | NOT MATCHED |
| 330006323 | 330003119 | 0 | 8.6 | Neo-adjuvant (N) | 2013-08-05 | 2013-10-26 | IRINOTECAN + OXALIPLATIN + PACLITAXEL | null | N | 330000951 | NOT MATCHED |
| 330006324 | 330003120 | null | 11.6 | Curative (C) | null | 2017-06-17 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330000957 | NOT MATCHED |
| 330006325 | 330003121 | 0 | 22.1 | Curative (C) | 2016-05-13 | 2016-09-01 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330000957 | NOT MATCHED |
| 330006326 | 330003121 | 1.62 | 45.5 | Curative (C) | 2015-04-30 | 2015-05-07 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330000957 | CISPLATIN + RT |
| 330006327 | 330003122 | 1.86 | 18.4 | null | 2014-04-01 | 2014-04-02 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | 330000980 | NOT MATCHED |
| 330006328 | 330003124 | 0 | null | Palliative (P) | 2016-08-02 | 2016-08-10 | NB HRNBL-1 TVD | N | N | 330000999 | NOT MATCHED |
| 330006329 | 330007669 | 1.74 | 72.2 | Curative (C) | 2016-06-01 | 2016-06-11 | Cisplatin + Radiotherapy | N | null | 330001002 | CISPLATIN + RT |
| 330006330 | 330003126 | null | null | Adjuvant (A) | 2015-04-16 | 2015-05-01 | CISPLATIN + RT | N | null | 330001024 | CISPLATIN + RT |
| 330006331 | 330003127 | 0 | 0 | Curative (C) | 2016-12-15 | 2016-12-21 | NB HRNBL-1 TVD | 02 | N | 330001039 | NOT MATCHED |
| 330006332 | 330007670 | 0 | 10.4 | null | 2015-07-15 | 2015-07-15 | NB HRNBL-1 COJEC Ind COURSE A | null | null | 330001040 | NOT MATCHED |
| 330006333 | 330003129 | 1.74 | 65.1 | Curative (C) | 2013-08-20 | 2014-04-28 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001050 | CISPLATIN + RT |
| 330006334 | 330003130 | 0 | 12.7 | Palliative (P) | 2014-11-18 | 2014-11-23 | NB HRNBL-1 Isotretinoin | Y | N | 330001087 | NOT MATCHED |
| 330006335 | 330003131 | null | 14.55 | Curative (C) | 2016-08-15 | 2016-08-31 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330001087 | NOT MATCHED |
| 330006336 | 330003132 | 0 | 59.1 | Curative (C) | 2017-07-07 | 2017-07-13 | CNS LGG 2004 03 cons vinc + carbo | N | null | 330001089 | NOT MATCHED |
| 330006337 | 330003134 | 0 | 8.9 | Curative (C) | 2011-09-03 | 2013-12-29 | EW EuroEwing 2012 Arm A VAC | 02 | N | 330001090 | NOT MATCHED |
| 330006338 | 330003136 | null | 63 | Adjuvant (A) | 2013-09-17 | 2013-12-16 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330001095 | CISPLATIN + RT |
| 330006339 | 330003137 | 1.57 | 42.3 | Curative (C) | 2013-11-20 | 2013-12-12 | NB HRNBL-1 BUMEL MAT | Y | N | 330001110 | NOT MATCHED |
| 330006340 | 330007673 | 0 | 13.9 | Neo-adjuvant (N) | 2016-02-06 | 2016-02-11 | NB HRNBL-1 ch14.18/CHO only (trial) | N | null | 330001110 | NOT MATCHED |
| 330006342 | 330003140 | 1.76 | 78 | Curative (C) | 2017-02-03 | 2017-03-31 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001131 | CISPLATIN + RT |
| 330006343 | 330003140 | 0 | null | Curative (C) | null | 2014-09-24 | NB Rel CCLG guidelines Cyclo-Topotecan | null | Y | 330001131 | NOT MATCHED |
| 330006344 | 330003141 | 1.81 | 7.6 | Curative (C) | 2016-03-29 | 2016-04-16 | LCHIV Salvage Cont P2 | Y | N | 330001136 | NOT MATCHED |
| 330006345 | 330007675 | null | null | Curative (C) | 2016-01-07 | 2016-01-17 | Cisplatin + Radiotherapy | null | Y | 330001136 | CISPLATIN + RT |
| 330006346 | 330007675 | 1.47 | null | Curative (C) | 2016-09-08 | 2016-11-16 | Cisplatin + Radiotherapy | null | Y | 330001136 | CISPLATIN + RT |
| 330006347 | 330003142 | 1.62 | null | Curative (C) | 2017-07-16 | 2017-08-30 | Cisplatin + Radiotherapy | Y | N | 330001144 | CISPLATIN + RT |
| 330006348 | 330003143 | 1.74 | 58.6 | Curative (C) | 2017-11-29 | 2017-11-30 | Cisplatin + Radiotherapy | null | Y | 330001162 | CISPLATIN + RT |
| 330006349 | 330003144 | null | 13.8 | Curative (C) | 2016-09-25 | 2016-09-26 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | N | 330001166 | NOT MATCHED |
| 330006354 | 330003147 | 0 | 19.2 | Curative (C) | 2014-05-02 | 2014-05-05 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | N | N | 330001213 | NOT MATCHED |